Skip to main content

RGNT · Regentis Biomaterials Ltd. · Holdings

Track RGNT — free
$1.47 -0.01 (-0.68%)
Market Cap
$10.40M
Shares
7.02M
Volume · Oct 20 13.66K Avg daily vol (3M) 59.01K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
Holders: 6
Total Value: $2,985,639
Total Shares: 845,791

Institutional Ownership Trend

3 quarters

Holder Concentration

Across 6 13F filers · Δ vs Mar 31, 2026
Top Holder
83.0%
Dec 2025 → Jun 2026 · range 54.4% – 89.5%
+28.6 pts
Top 5
100.0%
Dec 2025 → Jun 2026 · range 100.0% – 100.0%
−0.0 pts
Top 10
100.0%
Dec 2025 → Jun 2026 · range 100.0% – 100.0%
0.0 pts
HHI
7,017
Dec 2025 → Jun 2026 · range 5,033 – 8,070
Highly concentrated+1,985

Who Holds RGNT

Last 3 quarters through Jun 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026: 6 filers, like-for-like change +53.3%; actively managed books +53.3%.

Holder type Share Filers Change
Registered adviser 1.6% 1 new
Bank 0.1% 1 +29.9%
Unknown 98.4% 4 +50.9%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

6 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
0
0.000% of filers hold it in their top 10
Mar 31, 2026: 0
Holders above 5%
0
median weight 0.000%
Mar 31, 2026: 0
Crowding
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Top 10 holders
100.0%
of 13F shares, Herfindahl 0.702
Active holders
+53.3%
like-for-like share change of active filers
5% stakes on record
1
0 13D, 1 13G (0 institutional, 0 passive, 1 exempt)
How long holders have held it value-weighted 2.7 quarters
Under 1 year 100.0% 1 to 3 years 0.000% 3 years or more 0.000% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$2.86
estimated per share
Mar 31, 2026: $4.81
Quarter-end price
$3.53
implied by 13F values
Estimated gain or loss
+23.5%
price against the estimated cost
Estimated at a loss
0.301%
of costed 13F value

Estimated cost covers 17.0% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shareholder Targets

13F filers that own its peers but not RGNT, quarter ended Jun 30, 2026

RGNT has no holder-overlap peers, so these filers hold the largest Healthcare stocks: LLY, JNJ, ABBV, UNH, MRK, TMO, AMGN, AZN, GILD, ABT, ISRG, VRTX, CVS, DHR, SYK, BMY, PFE, MDT, MCK, ELV. 6,283 filers in all.

# Filer In peers
1 BlackRock, Inc. Holding company, Index-like $399,992,110,610 20 held
2 VANGUARD CAPITAL MANAGEMENT LLC Registered adviser, Index-like $308,266,564,827 20 held
3 STATE STREET CORP Bank, Index-like $222,713,276,889 20 held
4 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $116,012,260,024 20 held
5 GEODE CAPITAL MANAGEMENT, LLC Registered adviser, Index-like $112,944,926,328 19 held
6 LILLY ENDOWMENT INC Unknown, Unknown $108,400,867,760 1 held
7 FMR LLC Holding company, Diversified active $102,008,860,554 20 held
8 JPMORGAN CHASE & CO Bank, Diversified active $92,751,126,760 20 held
9 MORGAN STANLEY Holding company, Index-like $91,022,115,433 20 held
10 Capital World Investors Adviser, Diversified active $89,827,396,720 14 held

Quarterly Activity

vs Mar 31, 2026
New
4
Increased
2
Decreased
0
Sold Out
1
Unchanged
0

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +3
Institutional value: +77.1%
Shares held: +53.3%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
No qualifying movers this quarter.

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 6 of 6
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1912966 CUSIP M8211G108 Visit website Investor relations